Major contributions of comparative endocrinology to the development and exploitation of the incretin concept

Journal of Experimental Zoology Part A: Comparative Experimental Biology

Volumn 305, Issue 9, 2006, Pages 781-786

  Conlon, J Michael ^a   Patterson, Steven ^b   Flatt, Peter R ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; EXENDIN 4; GLUCAGON; GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 (7 36)AMIDE; GLUCAGON-LIKE PEPTIDE 1 (7-36)AMIDE; GLUCOSE; PEPTIDE; PEPTIDE FRAGMENT; VENOM;

AMINO ACID SEQUENCE; ANIMAL; CONFERENCE PAPER; FISH; FROGS AND TOADS; HUMAN; INTESTINE MUCOSA; MOLECULAR GENETICS; PHYSIOLOGY; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANIMALS; ANURA; FISHES; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDES; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INTESTINAL MUCOSA; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDES; SEQUENCE ALIGNMENT; VENOMS;

ANURA; HELODERMA SUSPECTUM; LOPHIUS AMERICANUS; TELEOSTEI;

EID: 33748504146     PISSN: 15488969     EISSN: 1552499X     Source Type: Journal    
DOI: 10.1002/jez.a.312     Document Type: Conference Paper

References (52)

1. Ali MF, Soto A, Knoop FC, Conlon JM. 2001. Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae). Biochim Biophys Acta 1500:81-89.
2. Andrews PC, Ronner P. 1985. Isolation and structures of glucagon and glucagon-like peptide from catfish pancreas. J Biol Chem 260:3910-3914.
3. Andrews PC, Hawke DH, Lee TD, Legesse K, Noe BD, Shively JE. 1986. Isolation and structure of the principal products of preproglucagon processing, including an amidated glucagon-like peptide. J Biol Chem 261:8128-8133.
4. Apponyi MA, Pukala TL, Brinkworth CS, Vaselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE. 2004. Host-defence peptides of Australian anurans: structure, mechanisms of action and evolutionary significance. Peptides 25:1035-1054.
5. Bayliss WM, Starling EH. 1902. The mechanism of pancreatic secretion. J Physiol 28:325-353.
6. Bell GI, Sanchez-Pescador R, Laybourn PJ, Najarian RC. 1983. Exon duplication and divergence in the human preproglucagon gene. Nature 304:368-371.
7. Buchanan KD, Vance JE, Williams RH. 1969. Insulin and glucagon release from isolated islets of Langerhans. Effect of enteric factors. Diabetes 18:381-386.
8. Chen YE, Drucker DJ. 1997. Tissue-specific expression of unique mRNAs that encode proglucagon-derived peptides or exendin 4 in the lizard. J Biol Chem 272:4108-4115.
9. Conlon JM. 2004. The therapeutic potential of antimicrobial peptides from frog skin. Rev Med Microbiol 15:17-25.
10. Conlon JM, Falkmer S, Thim L. 1987. Primary structures of three fragments of proglucagon from the pancreatic islets of the daddy Sculpin (Cottus scorpius). Eur J Biochem 164:117-122.
11. Conlon JM, Sonnevend A, Patel M, Vijayasarathy C, Nowotny N, Zilahi E, Iwamuro S, Nielsen PF, Pál T. 2003. A melittin-related peptide from the skin of the Japanese frog, Rana tagoi with antimicrobial and cytolytic properties. Biochem Biophys Res Commun 306:496-500.
12. Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF. 2004. The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei. Biochem Biophys Res Commun 320:170-175.
13. Creutzfeldt W. 2005. The [pre-] history of the incretin concept. Regul Pept 128:87-91.
14. Egan JM, Clocquet AR, Elahi D. 2002. The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes. J Clin Endocrinol Metab 87:1282-1290.
15. Elrick, H, Stimmler L, Hlad CJ, Arai Y. 1964. Plasma insulin responses to oral and intravenous glucose administration. J Clin Endocrinol Metab 24:1076-1082.
16. Eng J, Kleinman WA, Singh L, Singh G, Raufman JP. 1992. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem 267:7402-7405.
17. Goraya J, Knoop FC, Conlon JM. 1998. Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana. Biochem Biophys Res Commun 250:589-592.
18. Green BD, Gault VA, O'Harte FP, Flatt PR. 2004. Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents. Curr Pharm Des 10:3651-3662.
19. Holst JJ, Orskov C, Nielsen OV, Schwartz TW. 1987. Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett 211:169-174.
20. Irwin DM, Wong J. 1995. Trout and chicken proglucagon: alternative splicing generates mRNA transcripts encoding glucagon-like peptide 2. Mol Endocrinol 9:267-277.
21. Joy SV, Rodgers PT, Scates AC. 2005. Incretin mimetics as emerging treatments for type 2 diabetes. Ann Pharmacother 39:110-118.
22. Kreymann B, Williams G, Ghatei MA, Bloom SR. 1987. Glucagon-like peptide-1(7-36): a physiological incretin in man. Lancet 2:1300-1304.
23. La Barre J. 1932. Sur le possibilités d'un traitment du diabète par l'incretine. Bull Acad R Med Belg 12:620-634.
24. Lazarus LH, Attila M. 1993. The toad, ugly and venomous, wears yet a precious jewel in his skin. Prog Neurobiol 41:473-507.
25. Lund PK, Goodman RH, Habener JF. 1981. Pancreatic pre-proglucagons are encoded by two separate mRNAs. J Biol Chem 256:6515-6518.
26. Lund PK, Goodman RH, Montminy MR, Dee PC, Habener JF. 1983. Anglerfish islet pre-proglucagon II. Nucleotide and corresponding amino acid sequence of the cDNA. J Biol Chem 258:3280-3284.
27. Marenah L, Flatt PR, Orr DF, McClean S, Shaw C, Abdel-Wahab YH. 2004a. Skin secretion of the toad Bombina variegata contains multiple insulin-releasing peptides including bombesin and entirely novel insulinotropic structures. Biol Chem 385:315-321.
28. Marenah L, Flatt PR, Orr DF, McClean S, Shaw C, Abdel-Wahab YH. 2004b. Brevinin-1 and multiple insulin-releasing peptides in the skin of the frog Rana palustris. J Endocrinol 181:347-354.
29. Marenah L, McClean S, Flatt PR, Orr DF, Shaw C, Abdel-Wahab YH. 2004c. Novel insulin-releasing peptides in the skin of Phyllomedusa trinitatis frog include 28 amino acid peptide from dermaseptin BIV precursor. Pancreas 29:110-115.
30. Marenah L, Shaw C, Orr DF, McClean S, Flatt PR, Abdel-Wahab YH. 2004d. Isolation and characterisation of an unexpected class of insulinotropic peptides in the skin of the frog Agalychnis litodryas. Regul Pept 120:33-38.
31. Matutte B, Knoop FC, Conlon JM. 2000. Kassinatuerin-I: a peptide with broad-spectrum antimicrobial activity isolated from the skin of the Hyperoliid frog, Kassina senegalensis. Biochem Biophys Res Commun 268:433-436.
32. McClenaghan NH, Barnett CR, Ah-Sing E, Abdel-Wahab YH, O'Harte FP, Yoon TW, Swanston-Flatt SK, Flatt PR. 1996. Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion. Diabetes 45:1132-1140.
33. McIntyre N, Holsworth CD, Turner DA. 1964. New interpretation of oral glucose tolerance. Lancet 2:20-21.
34. Meier JJ, Nauck MA, Schmidt WE, Gallwitz B. 2002. Gastric inhibitory polypeptide; the neglected incretin revisited. Regul Pept 107:1-13.
35. Mojsov S, Weir GC, Habener JF. 1987. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79:616-619.
36. Moore B, Edie ES, Abram JH. 1906. On the treatment of diabetes mellitus by acid extract of duodenal mucous membrane. Biochem J 1:28-38.
37. Oehme C, Wimmers K. 1923. Wirkung von Duodenalschleimhautextracten (Secretin) auf den Blutzucker. Z Gesamte Exp Med 38:1-8.
38. Olson L, Soto A, Knoop FC, Conlon JM. 2001. Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog. Biochem Biophys Res Commun 288:1001-1005.
39. Parkes DG, Pittner R, Jodka C, Smith P, Young A. 2001. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Metabolism 50:583-589.
40. Plisetskaya E, Pollock HG, Rouse JB, Hamilton JW, Kimmel JR, Gorbman A. 1986. Isolation and structures of coho salmon (Oncorhynchus kisutch) glucagon and glucagon-like peptide. Regul Pept 14:57-67.
41. Raufman JP, Singh L, Singh G, Eng J. 1992. Truncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4. J Biol Chem 267:21432-21437.
42. Rolin B, Deacon CF, Carr RD, Ahren B. 2004. The major glucagon-like peptide-1 metabolite, GLP-1-(9-36)-amide, does not affect glucose or insulin levels in mice. Eur J Pharmacol 494:283-288.
43. Rollins-Smith LA, King JD, Nielsen PF, Sonnevend A, Conlon JM. 2005. An antimicrobial peptide from the skin secretions of the mountain chicken frog Leptodactylus fallax (Anura: Leptodactylidae). Regul Pept 124:173-178.
44. Samols E, Marri G, Marks V. 1966a. Interrelationship of glucagon, insulin and glucose. The insulinogenic effect of glucagon. Diabetes 15:855-866.
45. Samols E, Tyler J, Megyesi C, Marks V. 1966b. Immunochemical glucagon in human pancreas, gut and plasma. Lancet 2:727-729.
46. Schmidt WE, Siegel EG, Creutzfeldt W. 1985. Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia 28:704-707.
47. Takács L. 1927. Versuche mit Secretin. Mitteilung Blutzuckerverminderne Wirkung des Secretins bei gesunden Menschen und Diabetikern. Z Gesamte Exp Med 57:532-535.
48. Takeshima K, Chikushi A, Lee KK, Yonehara S, Matsuzaki K. 2003. Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes. J Biol Chem 278:1310-1315.
49. Thim L, Moody AJ. 1981. The primary structure of porcine glicentin (proglucagon). Regul Pept 2:139-150.
50. Unger RH, Eisentraut AM, McCall MS, Madison LL. 1961. Glucagon antibodies and an immunoassay for glucagon. J Clin Invest 40:1280-1289.
51. Unger RH, Ketterer H, Eisentraut AM. 1966. Distribution of immunoassayable glucagon in gastrointestinal tissues. Metabolism 15:865-867.
52. Vilsbøll T, Holst JJ. 2004. Incretins, insulin secretion and Type 2 diabetes mellitus. Diabetologia 47:357-366.